In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

BioAlliance, SpePharm form 50/50 JV; concluded

Executive Summary

BioAlliance Pharma SA (cancer and infectious disease therapeutics) and SpePharm BV are forming a 50/50 joint venture to commercialize BioAlliance's Loramyc (miconazole).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Marketing-Licensing
    • Intra-Biotech Deal
    • Joint Venture
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register